A case of disseminated tuberculosis presenting as a metastasizing tumor, complicated by toxic megacolon caused by Clostridium difficile: Difficulties in diagnosis
Magy Seb. 2024 Apr 2;77(1):15-22. doi: 10.1556/1046.2024.10004. Print 2024 Apr 2.ABSTRACTA mára ritkán előforduló tuberkulózis (tbc) extrapulmonális manifesztációi előrehaladott rosszindulatú daganatok képét utánozhatják, jelentős diagnosztikus dilemmákat okozva. A tbc igazolása gyakorta bonyolult, komplex vizsgálatokat igényel. Egy fiatal vietnámi nőbeteg esetét ismertetjük, aki idült hasi fájdalom, fogyás, fejfájás, bal oldali hemiparesis miatt jelentkezett kórházunkban. Az urgens vizsgálatok hasi folyadékgyülemek, lymphadenopathia és peritonealis carcinosis képe mellett az uterushoz as...
Source: Magyar Sebeszet - April 2, 2024 Category: Surgery Authors: G éza Telek Csaba Pol ányi Fanni F ülöp Hai Anh Thu Nguyen Kriszti án Kónya Ilona Bobek Edit Babarczi Ferenc Ender Source Type: research
A case of disseminated tuberculosis presenting as a metastasizing tumor, complicated by toxic megacolon caused by Clostridium difficile: Difficulties in diagnosis
Magy Seb. 2024 Apr 2;77(1):15-22. doi: 10.1556/1046.2024.10004. Print 2024 Apr 2.ABSTRACTA mára ritkán előforduló tuberkulózis (tbc) extrapulmonális manifesztációi előrehaladott rosszindulatú daganatok képét utánozhatják, jelentős diagnosztikus dilemmákat okozva. A tbc igazolása gyakorta bonyolult, komplex vizsgálatokat igényel. Egy fiatal vietnámi nőbeteg esetét ismertetjük, aki idült hasi fájdalom, fogyás, fejfájás, bal oldali hemiparesis miatt jelentkezett kórházunkban. Az urgens vizsgálatok hasi folyadékgyülemek, lymphadenopathia és peritonealis carcinosis képe mellett az uterushoz as...
Source: Magyar Sebeszet - April 2, 2024 Category: Surgery Authors: G éza Telek Csaba Pol ányi Fanni F ülöp Hai Anh Thu Nguyen Kriszti án Kónya Ilona Bobek Edit Babarczi Ferenc Ender Source Type: research
Clinical Efficacy of Therapeutic Agents for Clostridioides difficile Infection Based on Four Severity Classifications
Jpn J Infect Dis. 2024 Mar 29. doi: 10.7883/yoken.JJID.2023.483. Online ahead of print.ABSTRACTThe Japanese guidelines for the management of Clostridioides difficile infection (CDI) recommend metronidazole (MNZ) for non-severe cases and vancomycin (VCM) for severe cases. Here, we investigated the use of CDI antimicrobials and evaluated their clinical efficacy in four severity classifications and the validity of these classifications. A retrospective chart review was conducted on 137 inpatients with an initial positive C. difficile toxin test and initiation of CDI antimicrobials between April 2015 and March 2019. For the cl...
Source: Japanese Journal of Infectious Diseases - March 31, 2024 Category: Infectious Diseases Authors: Mariko Ohtani Sadako Yoshizawa Taito Miyazaki Eri Kumade Shinobu Hirayama Maki Sakamoto Hinako Murakami Tadashi Maeda Yoshikazu Ishii Takahiro Matsumoto Kazuhiro Tateda Source Type: research
Clinical Efficacy of Therapeutic Agents for Clostridioides difficile Infection Based on Four Severity Classifications
Jpn J Infect Dis. 2024 Mar 29. doi: 10.7883/yoken.JJID.2023.483. Online ahead of print.ABSTRACTThe Japanese guidelines for the management of Clostridioides difficile infection (CDI) recommend metronidazole (MNZ) for non-severe cases and vancomycin (VCM) for severe cases. Here, we investigated the use of CDI antimicrobials and evaluated their clinical efficacy in four severity classifications and the validity of these classifications. A retrospective chart review was conducted on 137 inpatients with an initial positive C. difficile toxin test and initiation of CDI antimicrobials between April 2015 and March 2019. For the cl...
Source: Japanese Journal of Infectious Diseases - March 31, 2024 Category: Infectious Diseases Authors: Mariko Ohtani Sadako Yoshizawa Taito Miyazaki Eri Kumade Shinobu Hirayama Maki Sakamoto Hinako Murakami Tadashi Maeda Yoshikazu Ishii Takahiro Matsumoto Kazuhiro Tateda Source Type: research
Clinical Efficacy of Therapeutic Agents for Clostridioides difficile Infection Based on Four Severity Classifications
Jpn J Infect Dis. 2024 Mar 29. doi: 10.7883/yoken.JJID.2023.483. Online ahead of print.ABSTRACTThe Japanese guidelines for the management of Clostridioides difficile infection (CDI) recommend metronidazole (MNZ) for non-severe cases and vancomycin (VCM) for severe cases. Here, we investigated the use of CDI antimicrobials and evaluated their clinical efficacy in four severity classifications and the validity of these classifications. A retrospective chart review was conducted on 137 inpatients with an initial positive C. difficile toxin test and initiation of CDI antimicrobials between April 2015 and March 2019. For the cl...
Source: Japanese Journal of Infectious Diseases - March 31, 2024 Category: Infectious Diseases Authors: Mariko Ohtani Sadako Yoshizawa Taito Miyazaki Eri Kumade Shinobu Hirayama Maki Sakamoto Hinako Murakami Tadashi Maeda Yoshikazu Ishii Takahiro Matsumoto Kazuhiro Tateda Source Type: research
Clinical Efficacy of Therapeutic Agents for Clostridioides difficile Infection Based on Four Severity Classifications
Jpn J Infect Dis. 2024 Mar 29. doi: 10.7883/yoken.JJID.2023.483. Online ahead of print.ABSTRACTThe Japanese guidelines for the management of Clostridioides difficile infection (CDI) recommend metronidazole (MNZ) for non-severe cases and vancomycin (VCM) for severe cases. Here, we investigated the use of CDI antimicrobials and evaluated their clinical efficacy in four severity classifications and the validity of these classifications. A retrospective chart review was conducted on 137 inpatients with an initial positive C. difficile toxin test and initiation of CDI antimicrobials between April 2015 and March 2019. For the cl...
Source: Japanese Journal of Infectious Diseases - March 31, 2024 Category: Infectious Diseases Authors: Mariko Ohtani Sadako Yoshizawa Taito Miyazaki Eri Kumade Shinobu Hirayama Maki Sakamoto Hinako Murakami Tadashi Maeda Yoshikazu Ishii Takahiro Matsumoto Kazuhiro Tateda Source Type: research
Clinical Efficacy of Therapeutic Agents for Clostridioides difficile Infection Based on Four Severity Classifications
Jpn J Infect Dis. 2024 Mar 29. doi: 10.7883/yoken.JJID.2023.483. Online ahead of print.ABSTRACTThe Japanese guidelines for the management of Clostridioides difficile infection (CDI) recommend metronidazole (MNZ) for non-severe cases and vancomycin (VCM) for severe cases. Here, we investigated the use of CDI antimicrobials and evaluated their clinical efficacy in four severity classifications and the validity of these classifications. A retrospective chart review was conducted on 137 inpatients with an initial positive C. difficile toxin test and initiation of CDI antimicrobials between April 2015 and March 2019. For the cl...
Source: Japanese Journal of Infectious Diseases - March 31, 2024 Category: Infectious Diseases Authors: Mariko Ohtani Sadako Yoshizawa Taito Miyazaki Eri Kumade Shinobu Hirayama Maki Sakamoto Hinako Murakami Tadashi Maeda Yoshikazu Ishii Takahiro Matsumoto Kazuhiro Tateda Source Type: research
Clinical Efficacy of Therapeutic Agents for Clostridioides difficile Infection Based on Four Severity Classifications
Jpn J Infect Dis. 2024 Mar 29. doi: 10.7883/yoken.JJID.2023.483. Online ahead of print.ABSTRACTThe Japanese guidelines for the management of Clostridioides difficile infection (CDI) recommend metronidazole (MNZ) for non-severe cases and vancomycin (VCM) for severe cases. Here, we investigated the use of CDI antimicrobials and evaluated their clinical efficacy in four severity classifications and the validity of these classifications. A retrospective chart review was conducted on 137 inpatients with an initial positive C. difficile toxin test and initiation of CDI antimicrobials between April 2015 and March 2019. For the cl...
Source: Japanese Journal of Infectious Diseases - March 31, 2024 Category: Infectious Diseases Authors: Mariko Ohtani Sadako Yoshizawa Taito Miyazaki Eri Kumade Shinobu Hirayama Maki Sakamoto Hinako Murakami Tadashi Maeda Yoshikazu Ishii Takahiro Matsumoto Kazuhiro Tateda Source Type: research
Clinical Efficacy of Therapeutic Agents for Clostridioides difficile Infection Based on Four Severity Classifications
Jpn J Infect Dis. 2024 Mar 29. doi: 10.7883/yoken.JJID.2023.483. Online ahead of print.ABSTRACTThe Japanese guidelines for the management of Clostridioides difficile infection (CDI) recommend metronidazole (MNZ) for non-severe cases and vancomycin (VCM) for severe cases. Here, we investigated the use of CDI antimicrobials and evaluated their clinical efficacy in four severity classifications and the validity of these classifications. A retrospective chart review was conducted on 137 inpatients with an initial positive C. difficile toxin test and initiation of CDI antimicrobials between April 2015 and March 2019. For the cl...
Source: Japanese Journal of Infectious Diseases - March 31, 2024 Category: Infectious Diseases Authors: Mariko Ohtani Sadako Yoshizawa Taito Miyazaki Eri Kumade Shinobu Hirayama Maki Sakamoto Hinako Murakami Tadashi Maeda Yoshikazu Ishii Takahiro Matsumoto Kazuhiro Tateda Source Type: research
Clinical Efficacy of Therapeutic Agents for Clostridioides difficile Infection Based on Four Severity Classifications
Jpn J Infect Dis. 2024 Mar 29. doi: 10.7883/yoken.JJID.2023.483. Online ahead of print.ABSTRACTThe Japanese guidelines for the management of Clostridioides difficile infection (CDI) recommend metronidazole (MNZ) for non-severe cases and vancomycin (VCM) for severe cases. Here, we investigated the use of CDI antimicrobials and evaluated their clinical efficacy in four severity classifications and the validity of these classifications. A retrospective chart review was conducted on 137 inpatients with an initial positive C. difficile toxin test and initiation of CDI antimicrobials between April 2015 and March 2019. For the cl...
Source: Japanese Journal of Infectious Diseases - March 31, 2024 Category: Infectious Diseases Authors: Mariko Ohtani Sadako Yoshizawa Taito Miyazaki Eri Kumade Shinobu Hirayama Maki Sakamoto Hinako Murakami Tadashi Maeda Yoshikazu Ishii Takahiro Matsumoto Kazuhiro Tateda Source Type: research
Clinical Efficacy of Therapeutic Agents for Clostridioides difficile Infection Based on Four Severity Classifications
Jpn J Infect Dis. 2024 Mar 29. doi: 10.7883/yoken.JJID.2023.483. Online ahead of print.ABSTRACTThe Japanese guidelines for the management of Clostridioides difficile infection (CDI) recommend metronidazole (MNZ) for non-severe cases and vancomycin (VCM) for severe cases. Here, we investigated the use of CDI antimicrobials and evaluated their clinical efficacy in four severity classifications and the validity of these classifications. A retrospective chart review was conducted on 137 inpatients with an initial positive C. difficile toxin test and initiation of CDI antimicrobials between April 2015 and March 2019. For the cl...
Source: Japanese Journal of Infectious Diseases - March 31, 2024 Category: Infectious Diseases Authors: Mariko Ohtani Sadako Yoshizawa Taito Miyazaki Eri Kumade Shinobu Hirayama Maki Sakamoto Hinako Murakami Tadashi Maeda Yoshikazu Ishii Takahiro Matsumoto Kazuhiro Tateda Source Type: research
Clinical Efficacy of Therapeutic Agents for Clostridioides difficile Infection Based on Four Severity Classifications
Jpn J Infect Dis. 2024 Mar 29. doi: 10.7883/yoken.JJID.2023.483. Online ahead of print.ABSTRACTThe Japanese guidelines for the management of Clostridioides difficile infection (CDI) recommend metronidazole (MNZ) for non-severe cases and vancomycin (VCM) for severe cases. Here, we investigated the use of CDI antimicrobials and evaluated their clinical efficacy in four severity classifications and the validity of these classifications. A retrospective chart review was conducted on 137 inpatients with an initial positive C. difficile toxin test and initiation of CDI antimicrobials between April 2015 and March 2019. For the cl...
Source: Japanese Journal of Infectious Diseases - March 31, 2024 Category: Infectious Diseases Authors: Mariko Ohtani Sadako Yoshizawa Taito Miyazaki Eri Kumade Shinobu Hirayama Maki Sakamoto Hinako Murakami Tadashi Maeda Yoshikazu Ishii Takahiro Matsumoto Kazuhiro Tateda Source Type: research
Clinical Efficacy of Therapeutic Agents for Clostridioides difficile Infection Based on Four Severity Classifications
Jpn J Infect Dis. 2024 Mar 29. doi: 10.7883/yoken.JJID.2023.483. Online ahead of print.ABSTRACTThe Japanese guidelines for the management of Clostridioides difficile infection (CDI) recommend metronidazole (MNZ) for non-severe cases and vancomycin (VCM) for severe cases. Here, we investigated the use of CDI antimicrobials and evaluated their clinical efficacy in four severity classifications and the validity of these classifications. A retrospective chart review was conducted on 137 inpatients with an initial positive C. difficile toxin test and initiation of CDI antimicrobials between April 2015 and March 2019. For the cl...
Source: Japanese Journal of Infectious Diseases - March 31, 2024 Category: Infectious Diseases Authors: Mariko Ohtani Sadako Yoshizawa Taito Miyazaki Eri Kumade Shinobu Hirayama Maki Sakamoto Hinako Murakami Tadashi Maeda Yoshikazu Ishii Takahiro Matsumoto Kazuhiro Tateda Source Type: research
Clinical Efficacy of Therapeutic Agents for Clostridioides difficile Infection Based on Four Severity Classifications
Jpn J Infect Dis. 2024 Mar 29. doi: 10.7883/yoken.JJID.2023.483. Online ahead of print.ABSTRACTThe Japanese guidelines for the management of Clostridioides difficile infection (CDI) recommend metronidazole (MNZ) for non-severe cases and vancomycin (VCM) for severe cases. Here, we investigated the use of CDI antimicrobials and evaluated their clinical efficacy in four severity classifications and the validity of these classifications. A retrospective chart review was conducted on 137 inpatients with an initial positive C. difficile toxin test and initiation of CDI antimicrobials between April 2015 and March 2019. For the cl...
Source: Japanese Journal of Infectious Diseases - March 31, 2024 Category: Infectious Diseases Authors: Mariko Ohtani Sadako Yoshizawa Taito Miyazaki Eri Kumade Shinobu Hirayama Maki Sakamoto Hinako Murakami Tadashi Maeda Yoshikazu Ishii Takahiro Matsumoto Kazuhiro Tateda Source Type: research
Clinical Efficacy of Therapeutic Agents for Clostridioides difficile Infection Based on Four Severity Classifications
Jpn J Infect Dis. 2024 Mar 29. doi: 10.7883/yoken.JJID.2023.483. Online ahead of print.ABSTRACTThe Japanese guidelines for the management of Clostridioides difficile infection (CDI) recommend metronidazole (MNZ) for non-severe cases and vancomycin (VCM) for severe cases. Here, we investigated the use of CDI antimicrobials and evaluated their clinical efficacy in four severity classifications and the validity of these classifications. A retrospective chart review was conducted on 137 inpatients with an initial positive C. difficile toxin test and initiation of CDI antimicrobials between April 2015 and March 2019. For the cl...
Source: Japanese Journal of Infectious Diseases - March 31, 2024 Category: Infectious Diseases Authors: Mariko Ohtani Sadako Yoshizawa Taito Miyazaki Eri Kumade Shinobu Hirayama Maki Sakamoto Hinako Murakami Tadashi Maeda Yoshikazu Ishii Takahiro Matsumoto Kazuhiro Tateda Source Type: research
